|
CTDSPL2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.976500E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.504900E-03 |
| Normal-vs-Stage2 |
1.302840E-01 |
| Normal-vs-Stage3 |
2.847000E-01 |
| Normal-vs-Stage4 |
7.644400E-01 |
| Stage1-vs-Stage2 |
5.223800E-01 |
| Stage1-vs-Stage3 |
3.722000E-01 |
| Stage1-vs-Stage4 |
3.304200E-01 |
| Stage2-vs-Stage3 |
8.875400E-01 |
| Stage2-vs-Stage4 |
6.340200E-01 |
| Stage3-vs-Stage4 |
7.469400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.716900E-03 |
| Normal-vs-AfricanAmerican |
5.489700E-02 |
| Normal-vs-Asian |
5.926000E-02 |
| Caucasian-vs-AfricanAmerican |
6.179800E-01 |
| Caucasian-vs-Asian |
7.455400E-01 |
| AfricanAmerican-vs-Asian |
6.012400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.601300E-04 |
| Normal-vs-Female |
6.000000E-01 |
| Male-vs-Female |
8.220800E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.591700E-02 |
| Normal-vs-Extreme_Weight |
4.633700E-04 |
| Normal-vs-Obese |
6.642500E-02 |
| Normal-vs-Extreme_Obese |
7.556400E-02 |
| Normal_Weight-vs-Extreme_Weight |
4.385200E-01 |
| Normal_Weight-vs-Obese |
6.287800E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.495400E-01 |
| Extreme_Weight-vs-Obese |
1.491590E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.996200E-01 |
| Obese-vs-Extreme_Obese |
7.171800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.033200E-01 |
| Normal-vs-Age(41-60Yrs) |
2.305800E-01 |
| Normal-vs-Age(61-80Yrs) |
1.583080E-04 |
| Normal-vs-Age(81-100Yrs) |
4.424900E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.263600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.100600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.587700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.176700E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.195800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.305000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.364300E-03 |
| Normal-VS-Type2 PRCC |
1.795530E-03 |
| Normal-VS-KIRP CIMP |
9.781600E-01 |
| Normal-VS-Unclassified PRCC |
5.024400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.595000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.444000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.675800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.223230E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.328620E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.949000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.041010E-04 |
| Normal-vs-N1 |
8.982600E-01 |
| Normal-vs-N2 |
5.048000E-01 |
| N0-vs-N1 |
4.029600E-02 |
| N0-vs-N2 |
6.836400E-01 |
| N1-vs-N2 |
5.313200E-01 |
|
|
